DK677688A - Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne - Google Patents
Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanneInfo
- Publication number
- DK677688A DK677688A DK677688A DK677688A DK677688A DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A
- Authority
- DK
- Denmark
- Prior art keywords
- human
- somatometricated
- procedures
- manufacturing
- protein substances
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3488587A | 1987-04-06 | 1987-04-06 | |
| PCT/US1988/001042 WO1988007863A1 (en) | 1987-04-06 | 1988-03-31 | Human somatomedin carrier protein subunits and process for producing them |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK677688A true DK677688A (da) | 1988-12-05 |
| DK677688D0 DK677688D0 (da) | 1988-12-05 |
Family
ID=21879212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK677688A DK677688D0 (da) | 1987-04-06 | 1988-12-05 | Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP0308500B1 (da) |
| JP (1) | JP2648951B2 (da) |
| AT (1) | ATE90690T1 (da) |
| AU (1) | AU627423B2 (da) |
| CA (1) | CA1340295C (da) |
| DE (1) | DE3881801T2 (da) |
| DK (1) | DK677688D0 (da) |
| ES (1) | ES2058341T3 (da) |
| IL (1) | IL85983A (da) |
| WO (1) | WO1988007863A1 (da) |
| ZA (1) | ZA882407B (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5973115A (en) * | 1987-05-15 | 1999-10-26 | Amgen Inc. | Method for potentiating and inhibiting insulin-like growth factor activity |
| US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
| EP0418230B1 (en) * | 1988-04-12 | 1995-12-27 | Amgen Boulder Inc. | Method for potentiating and inhibiting insulin-like growth factor activity |
| ATE125268T1 (de) * | 1988-07-15 | 1995-08-15 | Cent Sydney Area Health Serv | Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes. |
| US6465423B1 (en) | 1988-07-15 | 2002-10-15 | Central Sydney Area Health Service | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| US5324820A (en) * | 1988-07-15 | 1994-06-28 | Central Sydney Area Health Service | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| US5187151A (en) * | 1991-02-12 | 1993-02-16 | Genentech, Inc. | Use of binding protein with igf-i as an anabolic growth promoting agent |
| JPH10512235A (ja) * | 1994-07-20 | 1998-11-24 | セルトリックス ファーマシューティカルズ，インコーポレイテッド | 骨形成の促進および骨再造形の調節のためのｉｇｆ／ｉｇｆｂｐ複合体 |
| US6420518B1 (en) | 1997-04-04 | 2002-07-16 | Genetech, Inc. | Insulin-like growth factor agonist molecules |
| US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
| DK1141014T3 (da) | 1999-01-06 | 2005-04-11 | Genentech Inc | Insulinlignende vækstfaktor (IGF) i mutantvariant |
| WO2000040612A1 (en) | 1999-01-06 | 2000-07-13 | Genentech, Inc. | Insulin-like growth factor (igf) i mutant variants |
| AU2001263215A1 (en) | 2000-05-16 | 2001-11-26 | Genentech Inc. | Method for treating cartilage disorders |
| EP1401476A4 (en) | 2001-03-14 | 2006-03-08 | Genentech Inc | IGF ANTAGONIST PEPTIDES |
| ES2527871T3 (es) | 2003-05-01 | 2015-02-02 | Imclone Llc | Anticuerpos completamente humanos dirigidos contra el receptor del factor de crecimiento 1 similar a la insulina humana |
| ATE536186T1 (de) | 2003-09-12 | 2011-12-15 | Tercica Inc | Verfahren zur behandlung von igf-1 (insulin-like growth factor 1)-mangel |
| EP1670822A2 (en) | 2003-10-03 | 2006-06-21 | Genentech, Inc. | Igf binding proteins |
| JP2009501141A (ja) | 2005-06-17 | 2009-01-15 | イムクローン システムズ インコーポレイテッド | 転移性骨癌の治療のための受容体アンタゴニスト |
| JP5198289B2 (ja) | 2006-02-03 | 2013-05-15 | イムクローン・リミテッド・ライアビリティ・カンパニー | 前立腺癌の治療用アジュバントとしてのｉｇｆ−ｉｒアンタゴニスト |
| EA202090705A1 (ru) | 2017-09-11 | 2020-06-11 | Шайр Хьюман Дженетик Терапиз, Инк. | Способы и композиции, предназначенные для лечения хронических заболеваний легких |
| CN117098547A (zh) | 2020-10-19 | 2023-11-21 | 奥克希尔生物有限公司 | 适用于新生儿的组合物 |
| WO2023139115A1 (en) | 2022-01-19 | 2023-07-27 | Oak Hill Bio Limited | Compositions and methods for reducing oxidation of igf‐1/igfbp |
| WO2023242442A1 (en) | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Method of maturing/differentiating neurons and/or modulating the vagus nerve |
| WO2023242439A1 (en) | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Vascular stabilisation (preterm infants) |
| WO2023242440A1 (en) | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Treament of lungs in infants |
-
1988
- 1988-03-31 AT AT88904042T patent/ATE90690T1/de active
- 1988-03-31 EP EP88904042A patent/EP0308500B1/en not_active Expired - Lifetime
- 1988-03-31 WO PCT/US1988/001042 patent/WO1988007863A1/en active IP Right Grant
- 1988-03-31 JP JP63503623A patent/JP2648951B2/ja not_active Expired - Lifetime
- 1988-03-31 AU AU17020/88A patent/AU627423B2/en not_active Ceased
- 1988-03-31 ES ES88904042T patent/ES2058341T3/es not_active Expired - Lifetime
- 1988-03-31 DE DE88904042T patent/DE3881801T2/de not_active Expired - Fee Related
- 1988-04-05 CA CA000563309A patent/CA1340295C/en not_active Expired - Fee Related
- 1988-04-05 IL IL8598388A patent/IL85983A/en unknown
- 1988-04-06 EP EP88303041A patent/EP0294021A1/en active Pending
- 1988-04-07 ZA ZA882407A patent/ZA882407B/xx unknown
- 1988-12-05 DK DK677688A patent/DK677688D0/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3881801D1 (de) | 1993-07-22 |
| WO1988007863A1 (en) | 1988-10-20 |
| DE3881801T2 (de) | 1993-12-23 |
| ES2058341T3 (es) | 1994-11-01 |
| AU627423B2 (en) | 1992-08-27 |
| JP2648951B2 (ja) | 1997-09-03 |
| AU1702088A (en) | 1988-11-04 |
| CA1340295C (en) | 1998-12-29 |
| IL85983A (en) | 1994-10-07 |
| DK677688D0 (da) | 1988-12-05 |
| EP0308500B1 (en) | 1993-06-16 |
| JPH01502986A (ja) | 1989-10-12 |
| ZA882407B (en) | 1988-09-28 |
| IL85983A0 (en) | 1988-09-30 |
| ATE90690T1 (de) | 1993-07-15 |
| EP0308500A1 (en) | 1989-03-29 |
| EP0294021A1 (en) | 1988-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK677688A (da) | Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne | |
| DK95291D0 (da) | Rekombinante dna-molekyler | |
| DK564989D0 (da) | Bindingsproteiner | |
| US5043429B1 (en) | Protein fragments containing factor VIII binding domain of von willebrand factor | |
| WO1994004691A3 (en) | Dimer and multimer forms of single chain polypeptides | |
| DK643087D0 (da) | Fremgangsmaade til isomerisering af en kulbrintefoedestroem | |
| IL85878A0 (en) | Anticoagulant proteins,dna coding for them,processes for preparing them,pharmaceutical compositions containing them,monoclonal antibodies against such proteins and hybrid cell lines which secrete these antibodies | |
| DE69000338D1 (de) | Expressionssystem zur herstellung von chimaeren monoklonalen antikoerpern. | |
| FI97299C (fi) | Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi | |
| FI953525A (fi) | Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi | |
| DE69327059D1 (de) | Verfahren zur herstellung von testelementen | |
| HUT55800A (en) | Process for producing anticoagulant peptides | |
| AU576508B2 (en) | Sythetic peptides antigenically corresponding to brain specific proteinoids | |
| DE3881101D1 (de) | Monoklonal-antikoerper und methode fuer die bereitung von hybridoma, produzierend diese antikoerper. | |
| DK142147B (da) | Fremgangsmaade til rensning af serumproteinkonjugater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |